What amount sold does Alucent Biomedical, Inc. report in Form D filings?

The latest linked filings report $46.6M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Alucent Biomedical, Inc.'s most recent SEC filing?

Alucent Biomedical, Inc.'s most recent Form D filing was on 2023-04-20.

How many investors does Alucent Biomedical, Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Alucent Biomedical, Inc. offer?

Alucent Biomedical, Inc.'s SEC Form D filings indicate equity offerings.

Alucent Biomedical, Inc.

CIK: 0001631834·Biotechnology·SALT LAKE CITY, UT·Corporation

Reported Sold

$46,599,999

Total Filings

Identified Offerings

Last Filed

Apr 20, 2023

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Apr 20, 2023Form D — New notice

Reported sold: $11,200,000 · Target: $11,200,000

Rule 506(b)·1 investor

Oct 15, 2020Form D — New notice

Reported sold: $34,999,999 · Target: $34,999,999

Rule 506(b)·3 investors

Jan 27, 2015Form D — New notice

Reported sold: $400,000 · Target: $400,000

Rule 506(b)·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$46,599,999

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

James Corbett

Related Person

Appears on 2 filings

David Flicek

Related Person

Appears on 2 filings

Michael Elliot

Related Person

Appears on 1 filing

Julie Norton

Related Person

Appears on 1 filing

Fred Slunecka

Related Person

Appears on 1 filing

Myles D. Greenberg

Related Person

Appears on 1 filing

David Kapaska

Related Person

Appears on 1 filing

James Corbett

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 20, 2023	New	$11,200,000	$11,200,000	1
Oct 15, 2020	New	$34,999,999	$34,999,999	3
Jan 27, 2015	New	$400,000	$400,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

3Helix, Inc.

Biotechnology

Offering target: $10,000,000

Filed Sep 18, 2026